Philips has received clearance from the U.S. Food and Drug Administration (FDA) for the latest version of its UroNav image fusion system.
Philips UroNav system.Royal Philips
UroNav is designed to support clinicians with image guidance during prostate biopsies and focal therapy procedures. It fuses diagnostic MR images of the prostate with live ultrasound images for guided procedures in real-time, Philips said. The latest version includes a new advanced annotation workflow that supports clinicians during focal therapy procedures, helping deliver more precise, minimally invasive care.
In addition, UroNav is now more compatible with ultrasound devices and needle guides, and includes upgraded privacy and security protections and integration with Philips DynaCAD systems for radiology and urology, the company said.
